Insight Folios Inc Abb Vie Inc. Transaction History

Insight Folios Inc

$280 Million
Q3 2024

A detailed history of Insight Folios Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Insight Folios Inc holds 42,313 shares of ABBV stock, worth $7.62 Million. This represents 2.98% of its overall portfolio holdings.

Number of Shares

42,313

Previous 40,372 4.81%

Holding current value

$7.62 Million

Previous $6.92 Million 20.67%

% of portfolio

2.98%

Previous 2.84%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$163.84 - $199.33 $318,013 - $386,899	1,941 Added 4.81%	42,313 $8.36 Million
Q2 2024 Jul 18, 2024	BUY	$154.79 - $180.76 $116,402 - $135,931	752 Added 1.9%	40,372 $6.92 Million
Q1 2024 Apr 19, 2024	SELL	$159.82 - $182.1 $1.38 Million - $1.58 Million	-8,661 Reduced 17.94%	39,620 $7.21 Million
Q4 2023 Jan 10, 2024	BUY	$137.6 - $154.97 $260,889 - $293,823	1,896 Added 4.09%	48,281 $7.48 Million
Q3 2023 Oct 11, 2023	SELL	$133.59 - $154.65 $682,778 - $790,416	-5,111 Reduced 9.93%	46,385 $6.91 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $264,224 - $328,810	1,994 Added 4.03%	51,496 $6.94 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $85,898 - $98,924	594 Added 1.21%	49,502 $7.89 Million
Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $346,328 - $415,338	-2,504 Reduced 4.87%	48,908 $0
Q3 2022 Oct 19, 2022	BUY	$134.21 - $153.93 $141,994 - $162,857	1,058 Added 2.1%	51,412 $6.9 Million
Q2 2022 Jul 12, 2022	BUY	$137.62 - $174.96 $298,222 - $379,138	2,167 Added 4.5%	50,354 $7.71 Million
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $136,731 - $169,645	1,036 Added 2.2%	48,187 $7.81 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $129,560 - $163,931	1,206 Added 2.62%	47,151 $6.38 Million
Q3 2021 Oct 15, 2021	BUY	$106.4 - $120.78 $228,121 - $258,952	2,144 Added 4.89%	45,945 $4.96 Million
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $150,871 - $168,079	1,434 Added 3.38%	43,801 $4.93 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $54,321 - $59,801	531 Added 1.27%	42,367 $4.59 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $192,854 - $260,373	2,396 Added 6.08%	41,836 $4.48 Million
Q3 2020 Oct 15, 2020	BUY	$85.91 - $100.83 $120,875 - $141,867	1,407 Added 3.7%	39,440 $3.46 Million
Q2 2020 Jul 14, 2020	SELL	$73.37 - $98.18 $682,781 - $913,663	-9,306 Reduced 19.66%	38,033 $3.73 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $280,768 - $425,679	4,353 Added 10.13%	47,339 $3.61 Million
Q4 2019 Jan 29, 2020	BUY	$72.13 - $90.25 $3.1 Million - $3.88 Million	42,986 New	42,986 $3.81 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Folios Inc, based on Form 13F filings with the SEC.

News

Stay updated on Insight Folios Inc with notifications on news.

Account

Insight Folios Inc Abb Vie Inc. Transaction History